ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Convex Group posts Q2 2026 profit rise, beats forecasts

Specialty insurer Convex Group reported a 12% increase in Q2 2026 net profit, exceeding analyst expectations on strong underwriting margins and investment income.

PA
Priya Anand · Equities & Earnings Desk · 16 Aug 2026 · 1 min read
Share
Convex Group posts Q2 2026 profit rise, beats forecasts

Convex Group Ltd. on Friday reported a 12% year-over-year rise in net profit for the second quarter of 2026, topping market forecasts as underwriting margins expanded and investment income strengthened.

The specialty insurer said net profit reached $245 million in Q2 2026, up from $219 million in the same period a year earlier. Revenue grew 8% to $1.34 billion, driven by higher premium volumes in property and casualty lines, particularly in North America and Europe.

Underwriting margins improved to 14.2%, compared with 12.8% in Q2 2025, reflecting disciplined pricing and lower claims in key segments. Investment income rose 15% to $89 million, supported by gains in fixed-income and equity portfolios amid stable market conditions.

Analysts surveyed by Refinitiv had expected net profit of $225 million and revenue of $1.31 billion for the quarter. Shares in Convex Group were up 3.2% in early London trading following the results.

Chief Executive Officer Stephen Catlin said the results demonstrated the company’s resilience in a competitive market, with continued focus on underwriting discipline and selective growth in high-margin segments.

Convex Group, which listed on the London Stock Exchange in 2022, operates primarily in specialty insurance and reinsurance, serving corporate and commercial clients globally.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT